Full Title
A Phase 1, First-in-Human Study of the SMARCA2 Degrader, PLX-61639, in Patients with SMARCA4-Mutated Locally Advanced or Metastatic Solid TumorsPurpose
To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.
Contact
For more information or to see if you can join this study, please call Dr. Robin Guo’s office at 646-888-6950.
Protocol
26-099
Phase
Phase I (phase 1)
Investigator
Co-Investigators
Diseases
ClinicalTrials.gov ID
NCT07284186